Dr. Hoffman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
757 Westwood Plz
Los Angeles, CA 90095Phone+1 310-206-6766
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Infectious Disease, 2005 - 2008
- Brigham and Women's Hospital/Children's Hospital/Harvard Medical SchoolResidency, Internal Medicine/Pediatrics, 2000 - 2005
- David Geffen School of Medicine at UCLAClass of 2000
Certifications & Licensure
- CA State Medical License 2003 - 2027
- MA State Medical License 2003 - 2006
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- INTERVAL: Varying Intervals of ART to Improve Outcomes in HIV Start of enrollment: 2017 May 31
Publications & Presentations
PubMed
- Preferences for Hypertension Care in Malawi: A Discrete Choice Experiment Among People Living with Hypertension, With and Without HIV.Risa Hoffman, Khumbo Phiri, Pericles Kalande, Hannah Whitehead, Agnes Moses
AIDS and Behavior. 2025-01-01 - Telemedicine for HIV care: a cross-sectional survey of people living with HIV receiving care at two federally qualified health centers in Los Angeles during a mature p...Daisy Walker, Corrina Moucheraud, Derrick Butler, Christian Takayama, Steven Shoptaw
BMC Infectious Diseases. 2024-12-31 - Brief Report: Stated Preferences for Long-Acting Injectable ART Among Mobile Men Living With HIV in Malawi: A Qualitative Study.Marguerite Thorp, Sam Phiri, Khumbo Phiri, Isabella Robson, Misheck Mphande
Journal of Acquired Immune Deficiency Syndromes. 2024-12-15
Press Mentions
- Three Steps to Speedier HIV Med Approvals for Pregnant PeopleJune 10th, 2021
- Benefits Outweigh Risks of Dolutegravir for Women of Childbearing Age Living with HIV, Study ShowsApril 3rd, 2019
- Avoiding Dolutegravir in Young Women with HIV: Time for a Rethink?April 1st, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: